Given the scope of the opioid crisis and how it is affecting our communities, we believe state and federal laws must be examined to identify and implement solutions on a wide scale. Walmart supports the development and implementation of a national prescription drug tracking database that would allow all 50 states to exchange data within a centralized national database.
In addition, we support legislation in states and in Congress to require an up to seven-day limit for initial prescriptions issued for acute conditions and to require e-prescriptions for all controlled substance prescriptions. To date, 30 states have enacted laws or set rules limiting initial acute opioid prescriptions and over 20 states have enacted e-prescription legislation, leading to even further gains in reducing the risk of prescription opioid abuse and dependence.
We also are concerned that conflicting rules and guidance on opioid prescriptions from federal and state agencies has led to significant confusion and can impede efforts to tackle the crisis. Walmart supports efforts to raise awareness about these conflicts and to seek clarification where needed.